SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
about
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.Acute myeloid leukemia: 2014 update on risk-stratification and management.Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia.Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaOverexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemiaT-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression.Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments.Proteolytic Isoforms of SPARC Induce Adipose Stromal Cell Mobilization in Obesity.Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer.The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC.
P2860
Q33919296-9D637D25-9405-4164-99C5-57E6F66420D8Q34410598-69127807-31D1-417E-BEAD-BB36282739E7Q34665691-13FE3447-5CFD-4809-B2B3-FB95B9665C6DQ35068076-1E5A9878-182C-4F4A-A2C2-3C45D701B964Q35781530-C29A00C2-9C5D-45C5-9EAF-BF4EC9E83434Q36248867-D4776AA8-A9F6-4F92-BCDA-F8EE922E48F1Q36771874-4AEEE94D-E7D7-43C4-85C9-0848DDFF3F8BQ38261327-24AD0B9C-94A5-4D69-95AC-A22E6B414666Q38724335-5C3C4967-B60F-4EF2-AC8A-AD1CAF386E9FQ39304713-97432A14-CEE2-4F0C-98AF-2C2F9ED4E0FCQ40527980-91E5755E-202A-4215-9226-AF2E5D0E0AE7Q42362739-EF3E1DFE-8CFF-49C5-8F6D-39403CA6BE45Q49176545-059445B9-4BDC-4A06-855D-C5D1904D8FBFQ50057726-86F0EFB7-1B5C-40B7-B4FB-365FD700A19D
P2860
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@en
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@nl
type
label
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@en
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@nl
prefLabel
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@en
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@nl
P2093
P2860
P50
P356
P1476
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
@en
P2093
Adrienne M Dorrance
Andrew J Carroll
Brad N Bolon
Christopher Hickey
Danilo Perrotti
Jihane Khalife
Juliana M Benito
Michael A Caligiuri
Mirela Anghelina
P2860
P304
P356
10.1172/JCI70921
P407
P50
P577
2014-03-03T00:00:00Z